|
1
|
Li W, Yu Y, He H, Chen J and Zhang D:
Urinary kidney injury molecule-1 as an early indicator to predict
contrast-induced acute kidney injury in patients with diabetes
mellitus undergoing percutaneous coronary intervention. Biomed Rep.
3:509–512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McCullough PA and Sandberg KR:
Epidemiology of contrastinduced nephropathy. Rev Cardiovasc Med. 4
Suppl 5:3–9. 2003.
|
|
3
|
Morcos SK and Thomsen HS; European Society
of Urogenital Radiology, : European Society of Urogenital Radiology
guidelines on administering contrast media. Abdom Imaging.
28:187–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han WK, Bailly V, Abichandani R, Thadhani
R and Bonventre JV: Kidney injury molecule-1 (KIM-1): A novel
biomarker for human renal proximal tubule injury. Kidney Int.
62:237–244. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sudarsky D and Nikolsky E:
Contrast-induced nephropathy in interventional cardiology. Int J
Nephrol Renovasc Dis. 4:85–99. 2011.PubMed/NCBI
|
|
6
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu MY, Hsiang HF, Wong CS, Yao MS, Li YW,
Hsiang CY, Bai CH, Hsu YH, Lin YF and Tam KW: The effectiveness of
N-Acetylcysteine in preventing contrast-induced nephropathy in
patients undergoing contrast-enhanced computed tomography: A
meta-analysis of randomized controlled trials. Int Urol Nephrol.
45:1309–1318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sharma D: Hydration is critical for
prevention of contrast-induced nephropathy. JACC Cardiovasc Interv.
5:454–455. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Firouzi A, Eshraghi A, Shakerian F, Sanati
HR, Salehi N, Zahedmehr A, Kiani R, Madani M and Pedarzadeh A:
Efficacy of pentoxifylline in prevention of contrast-induced
nephropathy in angioplasty patients. Int Urol Nephrol.
44:1145–1149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Liu Y, Fu L, Mei C and Dai B:
Efficacy of short-term high-dose statin in preventing
contrast-induced nephropathy: A meta-analysis of seven randomized
controlled trials. PLoS One. 7:e344502012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang SL, Feng ZQ, Wu LS and Li LH: Shenfu
injection prevents kindney from acute ischemic-reperfusion injury
in rabbits. Chin J Pathophysiol. 19:353–356. 2003.
|
|
12
|
Hunt SA, Abraham WT, Chin MH, Feldman AM,
Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K,
et al American College of Cardiology; American Heart Association
Task Force on Practice Guidelines; American College of Chest
Physicians; International Society for Heart and Lung
Transplantation; Heart Rhythm Society, : ACC/AHA 2005 Guideline
Update for the Diagnosis and Management of Chronic Heart Failure in
the Adult: A report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Writing
Committee to Update the 2001 Guidelines for the Evaluation and
Management of Heart Failure): Developed in collaboration with the
American College of Chest Physicians and the International Society
for Heart and Lung Transplantation: Endorsed by the Heart Rhythm
Society. Circulation. 112:e154–e235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y,
Xu JS, Huang SM, Wang LN, Huang W, et al: Modified glomerular
filtration rate estimating equation for Chinese patients with
chronic kidney disease. J Am Soc Nephrol. 17:2937–2944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehran R: Contrast-induced nephropathy
remains a serious complication of PCI. J Interv Cardiol.
20:236–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartorelli AL and Marenzi G:
Contrast-induced nephropathy. J Interv Cardiol. 21:74–85. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Idée JM, Lancelot E, Berthommier C,
Couturier-Goulas V, Vazin V and Corot C: Effects of non-ionic
monomeric and dimeric iodinated contrast media on renal and
systemic haemodynamics in rats. Fundam Clin Pharmacol. 14:11–18.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomsen HS: How to avoid CIN: Guidelines
from the European Society of Urogenital Radiology. Nephrol Dial
Transplant. 20 Suppl 1:i18–i22. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trivedi HS, Moore H, Nasr S, Aggarwal K,
Agrawal A, Goel P and Hewett J: A randomized prospective trial to
assess the role of saline hydration on the development of contrast
nephrotoxicity. Nephron Clin Pract. 93:c29–34. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu W, Li C, Yin W, Hou X and Zhang D:
Effects of Shen-Fu injection on the expression of T-cell-specific
transcription factors T-bet/gata-3 in porcine postresuscitation
lung injury. Evid Based Complement Alternat Med 2013.
4646502013.
|
|
20
|
Liu XH, Hu CS, Ji NJ, Mei JH, Zhou DJ and
Fan BF: Effect of Shenfu injection on serum brain
natriureticpeptide levels in elderly patients with chronic
congestive heart failure patients. China Pharmaceuticals. 19:12–13.
2010.(In Chinese).
|
|
21
|
Hou YZ, Mao JY, Wang XL, Li J and Liu CH:
Shenfu Injection for patients with heart failure: A systematic
review. Chin J Evidence-Based Med. 11:292–299. 2011.(In
Chinese).
|
|
22
|
Liu JW and Dai YP: Introduction of
pharmacological action of Shenfu injection and clinical practice in
cardiovascular disease. Liaoning Zhongyiyao Daxue Xuebao.
12:242–244. 2010.
|
|
23
|
Nie YJ, Song HH and Qi CX: Effect of
Shenfu injection in the treatment of dilated cardiomyopathy with
heart failure clinical observation of 38 cases. China Med Pharm.
02:64–65. 2012.
|
|
24
|
Deng QY, Tao LT and Wang DW: Effect of
Shenfu injection on patients with cardiopulmonary resuscitation
clinical research. J New Chin Med. 44:15–17. 2012.
|
|
25
|
Zhu J, Kang L, Ye Q, Fan G, Liang Y, Yan C
and Orgah J: Effects of Shenfu injection and its main components on
the contraction of isolated rat thoracic aortic rings. PLoS One.
8:e780262013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li YH, Yu B, Duan ZZ, Akinyi OM, Yu JH,
Zhou K, Zhang Y and Gao XM: The coronary dilation effect of shen fu
injection was mediated through NO. PLoS One. 9:e924152014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xianyi L, Handong Z and Jinfu Y:
Protective effect of ShenFu injection on multiple organ damage in
rabbit during ischemia reperfusion. Chin J Anesthesiology.
7:1997.
|
|
28
|
Zheng SY, Sun J, Zhao X and Xu JG:
Protective effect of shen-fu on myocardial ischemia-reperfusion
injury in rats. Am J Chin Med. 32:209–220. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao L and Wei X: Shenfu injection to
treat chronic renal failure splenic kidney Yang deficiency syndrome
30 effect observation. Chin J Emergency Med. 18:1624–1626.
2009.
|
|
30
|
Bachorzewska-Gajewska H, Malyszko J,
Sitniewska E, Malyszko JS and Dobrzycki S: Neutrophil
gelatinase-associated lipocalin (NGAL) correlations with cystatin
C, serum creatinine and eGFR in patients with normal serum
creatinine undergoing coronary angiography. Nephrol Dial
Transplant. 22:295–296. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patti G, Nusca A, Chello M, Pasceri V,
D'Ambrosio A, Vetrovec GW and Di Sciascio G: Usefulness of statin
pretreatment to prevent contrast-induced nephropathy and to improve
long-term outcome in patients undergoing percutaneous coronary
intervention. Am J Cardiol. 101:279–285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jo SH, Koo BK, Park JS, Kang HJ, Cho YS,
Kim YJ, Youn TJ, Chung WY, Chae IH, Choi DJ, et al: Prevention of
radiocontrast medium-induced nephropathy using short-term high-dose
simvastatin in patients with renal insufficiency undergoing
coronary angiography (PROMISS) trial - a randomized controlled
study. Am Heart J. 155:499.e1-82008. View Article : Google Scholar : PubMed/NCBI
|
